These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31614120)

  • 1. From parasitic disease control to global health: New orientation of the National Institute of Parasitic Diseases, China CDC.
    Chen J; Ding W; Li Z; Zhou DD; Yang P; Wang RB; Zheng B; Sheng HF; Guan YY; Xiao N; Li SZ; Zhou XN
    Acta Trop; 2020 Jan; 201():105219. PubMed ID: 31614120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seventy years' achievements of international cooperation by the National Institute of Parasitic Diseases at the Chinese Center for Disease Control and Prevention.
    Wang RB; Hong YT; Zhou XN
    Infect Dis Poverty; 2020 Nov; 9(1):164. PubMed ID: 33256842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessing the correlation between international collaboration and academic influence in parasitic diseases: a case study of National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention].
    Yao JW; Jia TW; Zhou XN
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Aug; 25(4):367-74. PubMed ID: 24358743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of NIPD-CTDR to the parasitic diseases control and elimination in China: Memory of the 70th anniversary for NIPD-CTDR.
    Xiao N; Li SZ; Qian MB; Xia ZG; Yu Q; Liu Q; Lv S; Zhou XN
    Adv Parasitol; 2020; 110():401-427. PubMed ID: 32563333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SWOT Analysis of the National Survey on Current Status of Major Human Parasitic Diseases in China].
    ZHU HH; ZHOU CH; CHEN YD; ZANG W; XIAO N; ZHOU XN
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2015 Oct; 33(5):377-81. PubMed ID: 26931045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions and achievements on schistosomiasis control and elimination in China by NIPD-CTDR.
    Cao CL; Zhang LJ; Deng WP; Li YL; Lv C; Dai SM; Feng T; Qin ZQ; Duan LP; Zhang HB; Hu W; Feng Z; Xu J; Lv S; Guo JG; Li SZ; Cao JP; Zhou XN
    Adv Parasitol; 2020; 110():1-62. PubMed ID: 32563322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance and response systems for elimination of tropical diseases: summary of a thematic series in Infectious Diseases of Poverty.
    Zhou X; Yap P; Tanner M; Bergquist R; Utzinger J; Zhou XN
    Infect Dis Poverty; 2016 May; 5(1):49. PubMed ID: 27179509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in public health risk communication in China: lessons learned from SARS to H7N9.
    Frost M; Li R; Moolenaar R; Mao Q; Xie R
    BMC Public Health; 2019 May; 19(Suppl 3):475. PubMed ID: 32326919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological big data and analytical tools applied in the control programmes on parasitic diseases in China: NIPD's sustained contributions in 70 years.
    Xia S; Zheng JX; Wang XY; Xue JB; Hu JH; Zhang XQ; Zhou XN; Li SZ
    Adv Parasitol; 2020; 110():319-347. PubMed ID: 32563330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contributions and achievements on malaria control and forthcoming elimination in China over the past 70 years by NIPD-CTDR.
    Feng X; Xia ZG; Feng J; Zhang L; Yan H; Tang L; Zhou XN; Zhou S
    Adv Parasitol; 2020; 110():63-105. PubMed ID: 32563334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention: a new administrative structure for schistosomiasis control.
    Zhou XN; Chen JX; Chen MG; Bergquist R
    Acta Trop; 2005; 96(2-3):296-302. PubMed ID: 16126154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of academic impact of publications from National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention based on SCIE database in recent five years].
    Zhen L; Bin Z
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 Mar; 29(2):235-240. PubMed ID: 29469336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of the National Institute of Parasitic Diseases to the control of visceral leishmaniasis in China.
    Zhou ZB; Wang JY; Gao CH; Han S; Li YY; Zhang Y; Zhou XN
    Adv Parasitol; 2020; 110():185-216. PubMed ID: 32563325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective analysis of granted projects of the National Institute of Parasitic Disease, China CDC during 2002-2012].
    Zhou XJ; Guan YY; Zhang MQ; Xiong YH; Zheng B
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Apr; 32(2):159-60. PubMed ID: 25065220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and application of surveillance and response systems for parasitic diseases in China, led by NIPD-CTDR.
    Hao YW; Wang Q; Cao CL; Tian T; Zhu ZL; Xu J; Zhou S; Wu W; Chen Y; Zhang Y; Chen JX; Li SZ; Xiao N; Zhou XN
    Adv Parasitol; 2020; 110():349-371. PubMed ID: 32563331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major trends in human parasitic diseases in China.
    Li T; He S; Zhao H; Zhao G; Zhu XQ
    Trends Parasitol; 2010 May; 26(5):264-70. PubMed ID: 20400374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imported parasitic diseases in mainland China: current status and perspectives for better control and prevention.
    Song LG; Zeng XD; Li YX; Zhang BB; Wu XY; Yuan DJ; He A; Wu ZD
    Infect Dis Poverty; 2018 Aug; 7(1):78. PubMed ID: 30071901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of human parasitic diseases: Context and overview.
    Molyneux DH
    Adv Parasitol; 2006; 61():1-45. PubMed ID: 16735161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards global control of parasitic diseases in the Covid-19 era: One Health and the future of multisectoral global health governance.
    Ung L; Stothard JR; Phalkey R; Azman AS; Chodosh J; Hanage WP; Standley CJ
    Adv Parasitol; 2021; 114():1-26. PubMed ID: 34696842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.